Clinical Outcomes of Partial Two-Stage Revision with Femoral Stem Retention in Elderly Patients with Hip Periprosthetic Joint Infection
Journal of Clinical Medicine · 10.03.2026 · 15 (6) · 2102
DOI: 10.3390/jcm15062102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.03.2026. Verfasst von Ji Hoon Bahk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Periprosthetic joint infection (PJI) of the hip remains a challenging complication, particularly in elderly patients who may not tolerate repeated invasive procedures. While two-stage, one-stage, and 1.5-stage revisions are established strategies, an optimal approach for elderly patients with a well-fixed femoral stem remains unclear. This study evaluated the clinical outcomes of partial two-stage revision with femoral stem retention in elderly patients with hip PJI.
Methods
A retrospective review was conducted of patients aged 65 years or older who underwent two-stage revision for hip PJI without femoral stem extraction at a single institution and had a minimum follow-up of one year after the final treatment. Patients were treated with aggressive debridement, removal of all components except the femoral stem, and placement of an antibiotic-loaded cement spacer and beads. Clinical outcomes, infection eradication, complications, and functional status were assessed.
Results
Twenty-eight patients (28 hips) were included, with a mean age of 79.5 years and a mean follow-up of 46.2 months. The index arthroplasty was hemiarthroplasty in most cases (92.9%). Seventeen patients completed a second-stage revision, while 11 remained with cement spacer retention. Infection control was achieved in all patients (100%) at final follow-up, with initial infection control achieved in 96.4%. No recurrence of infection was observed in either group. Multidrug-resistant organisms were identified in 67.9% of cases. Functional outcomes were acceptable, and no stem-related complications or reinfections occurred.
Conclusions
Partial two-stage revision with femoral stem retention provided effective infection control and acceptable functional outcomes in elderly patients with hip PJI. This approach may be considered a reasonable treatment option for elderly patients with a well-fixed femoral stem when reducing surgical invasiveness is an important consideration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
- Department of Orthopedic Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si 18450, Republic of Korea.
- Department of Orthopedic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Ji Hoon Bahk, Young Wook Lim
Zitieren
APA
Bahk, J. H., Chang, J. D., Lim, Y. W., Kim, S., & Lee, K. H. (2026). Clinical Outcomes of Partial Two-Stage Revision with Femoral Stem Retention in Elderly Patients with Hip Periprosthetic Joint Infection. Journal of Clinical Medicine, 15(6), 2102. https://doi.org/10.3390/jcm15062102
Vancouver
Bahk JH, Chang JD, Lim YW, Kim S, Lee KH. Clinical Outcomes of Partial Two-Stage Revision with Femoral Stem Retention in Elderly Patients with Hip Periprosthetic Joint Infection. Journal of Clinical Medicine. 2026;15(6):2102. doi:10.3390/jcm15062102
BibTeX
@article{Bahk2026,
author = {Bahk, Ji Hoon and Chang, Jun-Dong and Lim, Young Wook and Kim, Sinje and Lee, Kee-Haeng},
title = {Clinical Outcomes of Partial Two-Stage Revision with Femoral Stem Retention in Elderly Patients with Hip Periprosthetic Joint Infection},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {6},
pages = {2102},
doi = {10.3390/jcm15062102}
}
EUVIMED